ACE2 and Hyperglycemia: As ACE2 expression is particularly amplified in key metabolic organs such as the liver, adipose tissue, and the small intestine (55–57), SARS-CoV-2 may attack these organs, resulting in insulin insensitivity and an exacerbation of hyperglycemia.